|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
Innovative Pulmonary Solutions Inc. Closed on $10 Million
2/13/2013 8:50:22 AM
Med-tech startup Innovative Pulmonary Solutions Inc. (IPS) has changed its name, moved its headquarters from Washington state to Plymouth, and closed on $10 million in venture capital. IPS announced last year that it would relocate from Bellevue, Wash., to the Twin Cities, after naming Dennis Wahr, a local serial med-tech entrepreneur, to serve as its CEO. The company said Monday it has changed its name to Holaira Inc. The startup's recent round of financing was led by its previous investors, including Advanced Technology Ventures, Morgenthaler Ventures, Eden Prairie-based Split Rock Partners, and Versant Ventures, which opened a Twin Cities office last year. Holaira is developing technology that aims to treat patients suffering from chronic obstructive pulmonary disease (COPD), a term that covers emphysema and chronic bronchitis.
|
|
|
|
|
|
|
|
|
|
|